Senestech Inc
NASDAQ:SNES
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.31
6.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Senestech Inc
NASDAQ:SNES
|
10.6m USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
528.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.6B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Senestech Inc
Glance View
SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona and currently employs 26 full-time employees. The company went IPO on 2016-12-08. The Company’s product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest is a liquid bait containing the active ingredients four vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest has two active ingredients, including 4-VCD and triptolide. Triptolide is derived from the thunder god vine Tripterygium wilfordii, used in traditional Chinese medicines and other over-the-counter supplements. Triptolide affects the reproductive capacity of both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The firm also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Senestech Inc is -253.5%, which is above its 3-year median of -547.5%.
Over the last 3 years, Senestech Inc’s Net Margin has increased from -1 115.6% to -253.5%. During this period, it reached a low of -1 115.6% on Aug 30, 2022 and a high of -253.5% on Oct 30, 2025.